A comparative study on the efficacy of platelet rich plasma vs conventional wound dressing in diabetic foot ulcers
DOI:
https://doi.org/10.18203/2349-2902.isj20191484Keywords:
Diabetic foot ulcer, Platelet-rich plasma, Wound healingAbstract
Background: The pathogenetic pathways and morbidity associated with diabetic foot ulcers render it a difficult clinical entity to manage. Newer biological methods such as platelet-rich plasma (PRP) are being investigated as improvements on conventional treatment techniques such as saline gauze antiseptic dressings.
Methods: The present study is a randomised controlled trial, with 25 subjects each in the PRP dressing and conventional dressing arms. It was conducted in the General Surgery wards of a tertiary care hospital among patients suffering from foot ulcers due to diabetes mellitus. PRP dressings were done biweekly for 4 weeks before final wound assessment.
Results: Most of the study population was males of more than 50 years of age. The lesions are predominantly on the plantar aspect. The inciting factor was trauma in around two-thirds of the cases. Nearly 80% of the subjects were on insulin for treatment. In the patients receiving treatment using PRP dressings, the wound contracted by more than 34% which was statistically significantly higher than those receiving conventional dressings.
Conclusions: Newer biological methods such as platelet-rich plasma (PRP) dressings offer a relatively novel safe and efficient technique for management of diabetic foot ulcers, compared to conventional methods.
Metrics
References
Adeghate J, Nurulain S, Tekes K, Fehér E, Kalász H, Adeghate E. Novel biological therapies for the treatment of diabetic foot ulcers. Expert Opin Biol Ther. 2017;17(8):979–87.
Dietrich I, Braga GA, de Melo FG, da Costa Silva Silva ACC. The Diabetic Foot as a Proxy for Cardiovascular Events and Mortality Review. Curr Atheroscler Rep. 2017;19(11):44.
Kasiewicz LN, Whitehead KA. Recent advances in biomaterials for the treatment of diabetic foot ulcers. Biomater Sci. 2017;5(10):1962–75.
Sinwar PD. The diabetic foot management - recent advance. Int J Surg. 2015;15:27–30.
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.
Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. BMJ. 2017;359:j5064.
Tindong M, Palle JN, Nebongo D, Aminde LN, Mboue-Djieka Y, Mbarga NTF, et al. Prevalence, Clinical Presentation, and Factors Associated With Diabetic Foot Ulcer in Two Regional Hospitals in Cameroon. Int J Low Extrem Wounds. 2018;17(1):42–7.
Ogbera OA, Osa E, Edo A, Chukwum E. Common clinical features of diabetic foot ulcers: perspectives from a developing nation. Int J Low Extrem Wounds. 2008;7(2):93–8.
Perez-Zabala E, Basterretxea A, Larrazabal A, Perez-Del-Pecho K, Rubio-Azpeitia E, Andia I. Biological approach for the management of non-healing diabetic foot ulcers. J Tissue Viability. 2016;25(2):157–63.
Mohammadi MH, Molavi B, Mohammadi S, Nikbakht M, Mohammadi AM, Mostafaei S, et al. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: A single-arm clinical trial. Transfus Apher Sci. 2017;56(2):160–4.
Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers. Ann Vasc Surg. 2017;38:206–11.
Babaei V, Afradi H, Gohardani HZ, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. J Wound Care. 2017;26(12):784–7.
Driver VR, Hanft J, Fylling CP, Beriou JM, Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52(6):68–70.
Mehrannia M, Vaezi M, Yousefshahi F, Rouhipour N. Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report. Can J Diabetes. 2014;38(1):5–8.
Hirase T, Ruff E, Surani S, Ratnani I. Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review. World J Diabetes. 2018;9(10):172–9.
Vicenti G, Bizzoca D, Caruso I, Nappi VS, Giancaspro G, Carrozzo M, et al. New insights into the treatment of non-healing diabetic foot ulcers. J Biol Regul Homeost Agents. 2018;32(6):15–21.
Pedras S, Carvalho R, Pereira Mda G. Sociodemographic and clinical characteristics of patients with diabetic foot ulcer. Rev Assoc Med Bras (1992). 2016;62(2):171–8.
Goda A, Metwally M, Ewada A, Ewees H. Platelet-rich plasma for the treatment of diabetic foot ulcer: a randomized, double-blind study. Egypt J Surg. 2018;37(2):178-84.
Tripathi K, Gupta P. Management of diabetic foot ulcers with platelet rich plasma: A clinical study. National J Clin Orthop. 2018;2(3):09–11.
Deshmukh NS, Belgaumkar VA, Tolat SN, Chavan RB, Vamja CJ. Platelet rich plasma in treatment of chronic non healing ulcers: a study of ten cases. Int J Res Dermatol. 2018;4(1):50–3.
Fernando ME, Crowther RG, Lazzarini PA, Sangla KS, Wearing S, Buttner P, et al. Plantar pressures are higher in cases with diabetic foot ulcers compared to controls despite a longer stance phase duration. BMC Endocrine Disorders. 2016;16(1):51.
Iraj B, Khorvash F, Ebneshahidi A, Askari G. Prevention of Diabetic Foot Ulcer. Int J Prev Med. 2013;4(3):373–6.
Rosyid FN. Etiology, pathophysiology, diagnosis and management of diabetics’ foot ulcer. Int J Res Med Sci. 2017;5(10):4206–13.
Singh SP, Kumar V, Pandey A, Pandey P, Gupta V, Verma R. Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study. J Wound Care. 2018;27(9):550–6.
Suthar M, Gupta S, Bukhari S, Ponemone V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J Biomed Sci. 2017;24(1):16.
